Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public...

53
Edward M. Gardner, MD Denver Public Health December 10, 2014

Transcript of Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public...

Page 1: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Edward M. Gardner, MD

Denver Public Health

December 10, 2014

Page 2: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

No financial relationships to disclose

No off-label discussions in presentation

Page 3: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Describe the evolution of the HIV care continuum and its applications

Discuss how engagement in HIV care across the spectrum of engagement promotes prevention of HIV transmission

Discuss what implications the HIV care continuum has on the work of ASOs/CBOs

Page 4: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 5: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Adapted from

Eldred et al AIDS Patient Care STDs 2007;21(Suppl1):S1-S2

Cheever Clin Infect Dis 2007;44:1500-2

Not in HIV Care Engaged in HIV Care

Unaware of

HIV infection

Aware of

HIV infection

(not in care)

Receiving some

medical care but

not HIV care

Entered HIV

care but lost to

follow-up

Cyclical or

intermittent user

of HIV care

Fully engaged

in HIV care

Page 6: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Mugavero et al. Clin Infect Dis. 2011;52:S238-S246

Page 7: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

19%

Gardner et al. Clin Infect Dis 2011;52(6):793–800

Page 8: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Slide Courtesy of Dr. Irene Hall, CDC IAC 2012 Abstract FRLBX05

Page 9: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

CDC Vital Signs 11/25/2014

Page 10: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

19% or 25% or 30%

Probably More!

Where are the problems?

• Accuracy and completeness of reported data

• Migration out of state and out of country

• Mortality data

Page 11: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

76%70%

62% 61%55% 55% 54% 54%

58%54%

9%16% 17% 22% 23% 21% 21% 18% 21%

17% 12% 11% 9% 9% 8% 8% 8% 7% 6%

5% 7% 9% 11% 10% 11% 14% 13% 14% 14%

2% 2% 2% 2% 3% 3% 3% 3% 2% 4%

21%29% 32%

37% 35% 33% 35% 37% 37% 36%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

6 12 18 24 30 36 42 48 54 60

Months After HIV Diagnosis

% in care %not retained %not linked

%out of state %expired % VL<200cps/ml

Rowan et al. IAC 2012 Poster MOPDC0305

Page 12: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Rowan et al. IAC 2012 Poster MOPDC0305

Page 13: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Dombrowski et al. JAIDS 2014;67(3):323-330.

Page 14: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 15: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Slide Courtesy of Dr. Irene Hall, CDC IAC 2012 Abstract FRLBX05

Page 16: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Nosyk et al. Lancet Infect Dis 2014;14:40-9.

Page 17: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Rowan et al. CROI 2012; Poster 1118.

Page 18: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

81% 92% 81% 86%

Supervie V. & Costagliola D. The spectrum of engagement in HIV care in France: strengths and gaps. 20th Conference on

Retroviruses and Opportunistic Infections. Atlanta, USA: March 2013. Abstract #: 1030.

Page 19: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

IAS 2013 Abstract:MOPE143

20%

Page 20: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Cascades provide a snapshot of HIV prevention and care services in a geographic area

May facilitate comparison of services in different locations, populations, and under different health care financing systems • Make sure definitions are the same for cascade

steps

Can facilitate tracking services over time

May facilitate health policy decisions regarding types and locations of services needed

Page 21: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 22: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Engagement with Prevention (HIV negative) • Pre-Exposure Prophylaxis (PrEP) • Non-occupational Post-Exposure Prophylaxis (NPEP) • Circumcision • Microbicides

Decreased risk behaviors (HIV positive or negative) • Sexual • Injection • Sero-adaptive behavior

Decreased HIV-RNA level (HIV positive) • Access to antiretroviral therapy • Adherence to antiretroviral therapy

Page 23: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 24: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Youth Risk Behavior Survey (YRBS) MMWR 2012;61(29):556-60.

Page 25: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Liu et al. PLoS Med 2014;11(3):e1001613

Page 26: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 27: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Marks et al. JAIDS 2005;39:446-53.

UAV = Unprotected Anal or Vaginal Intercourse

Page 28: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 29: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Metsch et al. Clin Infect Dis 2008;47:577-84.

Page 30: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 31: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Dombrowski et al. JAIDS 2013;63:299-306.

Page 32: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Quarters with an HIV Clinic Visit

Adherence by Pharmacy Refill

P-value (overall)

4 79% P<0.001

3 74%

2 68%

1 59%

Adherence was higher in newly engaging patients with better

engagement in care over one year (number of quarters with

an HIV Clinic Visit

Giordano et al. Clin Infect Dis. 2007;44:1493-9.

Page 33: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 34: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Fu et al. AIDS 2012;26:2383-91.

Page 35: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Ch

an

ge

in

HIV

-1 R

NA

(lo

g 1

0 c

op

ies/m

l)

Hammer et al. NEJM 1997;337:725-33.

Dual Nucleosides

Indinavir + Dual Nucleosides

Page 36: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Patterson et al. Ann Intern Med. 2000;133:21-30.

Page 37: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 38: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Connor et al. NEJM. 1994;331:1173-80.

Page 39: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 40: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

NEJM 2011;365: 493-505.

HPTN-052

96% reduction

In HIV incidence

Page 41: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 42: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

It is more readily apparent that prevention and treatment are part of the same continuum

Funding is becoming streamlined

• CDC – HIV testing and prevention

• HRSA – HIV treatment and care

Gives structure to our conversations

• With funders, HCWs, patients, clients

Allows us to measure and track our efforts

Page 43: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Patients/Clients

Activists

Providers and Health Care Workers

Community Based Organizations

Community members

Health departments

Funders

Page 44: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Social support Outreach and navigation (Next Slides) Improve messaging on the importance of

engagement (Next Slides) Substance abuse counseling and treatment Mental Health diagnosis and care Universal Health Care? (Next Slides) Improve housing and decrease homelessness Decrease competing needs (food, clothing, etc.) Improve the system of health care delivery

Page 45: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Observational demonstration project (Special Projects of National Significance, SPNS)

Underserved recently diagnosed individuals • women, youth, substance abuse, mental illness

Intensive outreach defined as • HIV education and support

• Addressing stigma

• Helping individuals access resources

• Addressing structural barriers to care

Naar-King et al. AIDS Pat Care STDs 2007;21 (Suppl1): S40-8

Page 46: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

104 participants had an average of 19 contacts over 12 months, 15 minutes per contact

Results:

• 81% had two visits over the first year

• 45% undetectable viral load at 12 months

• 50% of uninsured gained insurance at 12 months

• 50% reduction in self-reported stigma as barrier

• 50% reduction in unmet support service need

Naar-King et al. AIDS Pat Care STDs 2007;21 (Suppl1): S40-8

Page 47: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Another SPNS publication

Peer patient Navigation supported: • Coaching patients

• Health system navigation

• Community linkages

437 individuals followed • Engagement at 6 months improved 64% to 87%

• 79% were still engaged at 12 months

• 50% increase in rates of viral suppression

Bradford et al. AIDS Pat Care STDs 2007;21 (Suppl1): S49-58

Page 48: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

The messaging intervention included: • Print reminder material including brochures and

posters that encouraged staying in care and contained information on: • The importance of staying in care

• Clinic contact numbers

• Research showing better health with regular care

• Brief verbal messages used by all clinic staff • “Thank you for doing such a good job of keeping your

appointments. It makes it easier for all of us to work together to keep you healthy.”

Gardner L et al. Clin Infect Dis 2012;55:1124-34

Page 49: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Gardner L et al. Clin Infect Dis 2012;55:1124-34

Table 2. Adjusted Percentage of Patients Keeping Next 2 Primary Care Visits During

Preintervention and Intervention Periods, 2008 - 2010

Table 3. Adjusted Mean Proportion of All Primary Care Visits Among Patients During

Preintervention and Intervention Periods, 2008 - 2010

Page 50: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Colorado expanded Medicaid and started a State-Wide Exchange in 2014

In 2014 we witnessed the following at our clinic:

• Uninsured dropped from 60% to 15%

• Medicaid increased from 15% to 50%

• Private insurance (exchange) increased from 5% to 15%

No data yet on the impact on engagement in HIV care

Page 51: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Slide Courtesy of Karen Robinson and David Heal, Washington State DOH

Page 52: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions
Page 53: Edward M. Gardner, MD Denver Public Health December 10, 2014 · Edward M. Gardner, MD Denver Public Health December 10, 2014 No financial relationships to disclose No off-label discussions

Webinars are available on our website for on-demand viewing.

You will find slides from today’s presentation posted to front page of our website: www.nationalhivcenter.org

Please complete the evaluation at the end of the webinar. Your feedback will inform our programming.

If you are interested in individualized technical assistance, please visit our website and complete a TA Request Form.

Join us for our next webinar!

Sustainability: The State of HIV/AIDS Service Organizations Wednesday, December 16 at 3:00 PM ET

(Find a link to register at our website: www.nationalhivcenter.org )